DR. ARVIND KUMAR MORYA (M17612)

Abstract

“WITHOUT HONEST RESEARCH&ROBUST VALIDATIONS IN OUR MEDICAL FIELD, SCIENCE SIMPLY GONNA DIE”IN THIS ERA OF EVIDENCE BASED MEDICINE WE HAVE SIMPLE RETROSPECTIVE STUDY TO COMPLEX RANDOMIZED,MULTICENTRIC, CLINICAL TRIALS. EARLIER OBSTACLES LIKE PRIORITY OF HEALTHCARE, LACK OF FUNDING&INFRASTRUCTURAL SUPPORT FROM THE INSTITUTES AND NON CONDUCIVEENVIRONMENT. THAT LEAD TO EXODUS OF HIGH QUALITY OPHTHALMIC SCIENTISTS FROM INDIA BUT TIDES ARE STREAMING IN POSITIVE DIRECTIONS NOW.UPTO 65% OF US FDA TRIALS ARE BEING OUTSOURCED TO OTHER COUNTRIES SO IN POST COVID ERA INDIA IS A GREAT CHOICE. MORE AND MORE ACCREDITED AND DEDICATED OPHTHALMIC RESEARCH LABS ARE COMING UP WITH ADVANCED COMMUNIQUE AND TECHNIQUE LEVELS.PUBMED PUBLICATION FROM INDIAN AUTHORS ARE ON A MANYFOLDRISE.THE AGENCIES LIKE IEC,ICMR,DBT & DST PROMOTING OCULAR RESEARCH IN TERMS OF FUNDING AND APPOINTMENTS.SO DEFINITELY THERE IS A SILVER – LINING FOR FULL TIME OPHTHALMIC RESEARCHERS IN VASTLY GROWING INDIAN SCIENTIFIC SCENARIO.

1	ROLE OF OPHTHALMIC RESEARCHERS IN CURRENT SCENARIO (15 mins)	DR. ARVIND KUMAR MORYA	watch video
2	HURDLES IN DOING RESEARCH IN OPHTHALMOLOGY (10 mins)	Dr. BAIRWA ASHOK KUMAR	watch video
3	WHAT, WHEN AND HOW OF THE CLINICAL TRIALS (10 mins)	Dr. RAJENDRA PRASAD	watch video
4	PLAN YOUR RESEARCH: WHAT STARTS WELL THAT ONLY ENDS WELL (10 mins)	Dr. SIDDHARAM JANTI	watch video
5	ONLY RESEARCH IS NOT ENOUGH – PUBLICATION IS A MUST (10 mins)	DR. INDER M. RUSTAGI	watch video
6	HOW TO FIND SOURCE OF FUNDING -COLLABORATION WITH PHARMACEUTICALS/SURGICAL COMPANY (10 mins)	Dr. MANOJ CHANDRA MATHUR	watch video
	Panel Discussion : (10 mins.)